Annual Current Liabilities
$47.40 M
+$26.12 M+122.80%
December 31, 2024
Summary
- As of March 12, 2025, PTGX annual total current liabilities is $47.40 million, with the most recent change of +$26.12 million (+122.80%) on December 31, 2024.
- During the last 3 years, PTGX annual current liabilities has risen by +$3.38 million (+7.68%).
- PTGX annual current liabilities is now at all-time high.
Performance
PTGX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$47.40 M
+$2.82 M+6.33%
December 31, 2024
Summary
- As of March 12, 2025, PTGX quarterly total current liabilities is $47.40 million, with the most recent change of +$2.82 million (+6.33%) on December 31, 2024.
- Over the past year, PTGX quarterly current liabilities has increased by +$2.82 million (+6.33%).
- PTGX quarterly current liabilities is now -9.28% below its all-time high of $52.25 million, reached on September 30, 2017.
Performance
PTGX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PTGX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +122.8% | +6.3% |
| 3 y3 years | +7.7% | +6.3% |
| 5 y5 years | +33.9% | +6.3% |
PTGX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.8% | at high | +122.8% |
| 5 y | 5-year | at high | +122.8% | at high | +122.8% |
| alltime | all time | at high | +3411.0% | -9.3% | +1416.3% |
Protagonist Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $47.40 M(+122.8%) | $47.40 M(+6.3%) |
| Sep 2024 | - | $44.58 M(+7.2%) |
| Jun 2024 | - | $41.58 M(+4.2%) |
| Mar 2024 | - | $39.91 M(+87.6%) |
| Dec 2023 | $21.27 M(-31.8%) | $21.27 M(-23.7%) |
| Sep 2023 | - | $27.87 M(+5.6%) |
| Jun 2023 | - | $26.40 M(+13.6%) |
| Mar 2023 | - | $23.23 M(-25.5%) |
| Dec 2022 | $31.18 M(-29.2%) | $31.18 M(-15.2%) |
| Sep 2022 | - | $36.75 M(-8.3%) |
| Jun 2022 | - | $40.09 M(-7.8%) |
| Mar 2022 | - | $43.46 M(-1.3%) |
| Dec 2021 | $44.02 M(+9.4%) | $44.02 M(+12.4%) |
| Sep 2021 | - | $39.16 M(-8.9%) |
| Jun 2021 | - | $42.97 M(+24.5%) |
| Mar 2021 | - | $34.52 M(-14.2%) |
| Dec 2020 | $40.24 M | $40.24 M(+4.4%) |
| Sep 2020 | - | $38.56 M(+9.1%) |
| Jun 2020 | - | $35.36 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $36.37 M(+2.7%) |
| Dec 2019 | $35.41 M(+35.4%) | $35.41 M(+15.0%) |
| Sep 2019 | - | $30.78 M(-7.6%) |
| Jun 2019 | - | $33.32 M(+36.0%) |
| Mar 2019 | - | $24.50 M(-6.3%) |
| Dec 2018 | $26.16 M(-38.5%) | $26.16 M(+8.5%) |
| Sep 2018 | - | $24.10 M(-16.9%) |
| Jun 2018 | - | $29.02 M(-14.5%) |
| Mar 2018 | - | $33.92 M(-20.3%) |
| Dec 2017 | $42.55 M(+561.3%) | $42.55 M(-18.6%) |
| Sep 2017 | - | $52.25 M(+457.8%) |
| Jun 2017 | - | $9.37 M(+20.4%) |
| Mar 2017 | - | $7.78 M(+20.9%) |
| Dec 2016 | $6.43 M(+105.9%) | $6.43 M(+20.3%) |
| Sep 2016 | - | $5.35 M(+30.1%) |
| Jun 2016 | - | $4.11 M(-8.1%) |
| Mar 2016 | - | $4.47 M(+43.0%) |
| Dec 2015 | $3.13 M(+131.6%) | $3.13 M |
| Dec 2014 | $1.35 M | - |
FAQ
- What is Protagonist Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual current liabilities year-on-year change?
- What is Protagonist Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly current liabilities year-on-year change?
What is Protagonist Therapeutics annual total current liabilities?
The current annual current liabilities of PTGX is $47.40 M
What is the all time high annual current liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual total current liabilities is $47.40 M
What is Protagonist Therapeutics annual current liabilities year-on-year change?
Over the past year, PTGX annual total current liabilities has changed by +$26.12 M (+122.80%)
What is Protagonist Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PTGX is $47.40 M
What is the all time high quarterly current liabilities for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly total current liabilities is $52.25 M
What is Protagonist Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PTGX quarterly total current liabilities has changed by +$2.82 M (+6.33%)